Royal Bank Of Canada Exagen Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Exagen Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 335 shares of XGN stock, worth $1,045. This represents 0.0% of its overall portfolio holdings.
Number of Shares
335Holding current value
$1,045% of portfolio
0.0%Shares
15 transactions
Others Institutions Holding XGN
# of Institutions
43Shares Held
6.05MCall Options Held
1.1KPut Options Held
6.4K-
Rtw Investments, LP New York, NY1.51MShares$4.72 Million0.1% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$2.78 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY535KShares$1.67 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$1.53 Million0.0% of portfolio
-
Morgan Stanley New York, NY484KShares$1.51 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $50.7M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...